In a human chondrosarcoma cell HBT-94 model, BBR activated the PI3K/Akt and p38 signaling pathways, increased the protein levels of p53 and p21, and triggered G2/M phase arrest, thus demonstrating anti-cancer effects (Eo et al., 2014). The gene discussed is AKT1; the disease is cancer.